| __timestamp | Halozyme Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79696000 | 396000000 |
| Thursday, January 1, 2015 | 93236000 | 364000000 |
| Friday, January 1, 2016 | 150842000 | 376000000 |
| Sunday, January 1, 2017 | 150643000 | 382000000 |
| Monday, January 1, 2018 | 150252000 | 432000000 |
| Tuesday, January 1, 2019 | 140804000 | 457000000 |
| Wednesday, January 1, 2020 | 34236000 | 463000000 |
| Friday, January 1, 2021 | 35672000 | 508000000 |
| Saturday, January 1, 2022 | 66607000 | 539000000 |
| Sunday, January 1, 2023 | 76363000 | 614000000 |
| Monday, January 1, 2024 | 79048000 | 686000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, innovation is the key to staying ahead. Zoetis Inc. and Halozyme Therapeutics, Inc. are two prominent players, each with a distinct approach to research and development (R&D) spending. Over the past decade, Zoetis has consistently outpaced Halozyme in R&D investment, with expenditures peaking at approximately 614 million in 2023, a 55% increase from 2014. In contrast, Halozyme's R&D spending has been more volatile, reaching its highest point in 2016 at around 151 million, before dipping significantly in subsequent years. This disparity highlights Zoetis's commitment to innovation, investing nearly four times more than Halozyme on average. As the pharmaceutical industry continues to prioritize groundbreaking research, understanding these spending patterns offers valuable insights into each company's strategic priorities and potential for future growth.
Research and Development Expenses Breakdown: Novartis AG vs Halozyme Therapeutics, Inc.
R&D Spending Showdown: Pfizer Inc. vs Zoetis Inc.
R&D Spending Showdown: Zoetis Inc. vs Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Zoetis Inc. vs Alkermes plc
Research and Development Investment: Zoetis Inc. vs Vericel Corporation
Research and Development: Comparing Key Metrics for Genmab A/S and Halozyme Therapeutics, Inc.
Research and Development Expenses Breakdown: Halozyme Therapeutics, Inc. vs Viking Therapeutics, Inc.
Research and Development Investment: Halozyme Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and HUTCHMED (China) Limited
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and Geron Corporation